Verrica Pharmaceuticals Inc (VRCA)
1.69
+0.01
(+0.60%)
USD |
NASDAQ |
Sep 27, 16:00
1.66
-0.03
(-1.78%)
After-Hours: 20:00
Verrica Pharmaceuticals Gross Profit (Quarterly): 4.635M for June 30, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.635M |
| March 31, 2024 | 2.688M |
| December 31, 2023 | 1.716M |
| September 30, 2023 | 2.647M |
| June 30, 2023 | 0.046M |
| Date | Value |
|---|---|
| March 31, 2023 | -0.031M |
| December 31, 2022 | 0.006M |
| September 30, 2022 | 8.153M |
| June 30, 2022 | -0.005M |
| March 31, 2022 | 0.153M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-0.031M
Minimum
Mar 2023
8.153M
Maximum
Sep 2022
2.001M
Average
0.9345M
Median
Gross Profit (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 581.57M |
| Zevra Therapeutics Inc | 0.876M |
| scPharmaceuticals Inc | 5.754M |
| TELA Bio Inc | 11.07M |
| Terns Pharmaceuticals Inc | -- |